Abdollahian Neil 4
4 · Cidara Therapeutics, Inc. · Filed Jan 6, 2020
Insider Transaction Report
Form 4
Abdollahian Neil
Chief Business Officer
Transactions
- Sale
Common Stock
2020-01-03$3.42/sh−2,340$8,003→ 51,248 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 12/31/19. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2019.